金活医药集团(01110)：张建斌辞任独立非执行董事

Core Viewpoint - Kingworld Medicines Group (01110) announced the resignation of Mr. Zhang Jianbin as an independent non-executive director, effective from August 1, 2025, to allocate more time to his other private affairs [1] Summary by Sections - Resignation Announcement - Mr. Zhang Jianbin has submitted his resignation as an independent non-executive director, chairman of the remuneration committee, member of the audit committee, and member of the nomination committee [1] - Succession Plan - Following Mr. Zhang's resignation, Dr. Chu Xiaoping has been appointed as the chairman of the remuneration committee, effective from August 1, 2025 [1]